EoCene Ltd. (EOCN) income statement
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.78+0.03 (+1.73%)
Close on Nov 20, 2026Market cap $1.78MP/E –Yield –
EoCene Ltd. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $1.78MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||||
| Operating margin | – | – | – | – | – | – | – | -525.8% | -1,139.5% | – | – | – | – | – | – |
| EBITDA margin | – | – | – | – | – | – | – | -506.8% | -1,117.5% | – | – | – | – | – | – |
| Pre-tax margin | – | – | – | – | – | – | – | -479.9% | -1,133.5% | -3,607.5% | – | – | – | – | – |
| Free cash flow margin | – | – | – | – | – | – | – | -447.2% | -1,113.3% | -2,600.9% | – | – | – | – | – |
| Returns on capital | |||||||||||||||
| Return on equity | -64.2% | -49.8% | -50.6% | -81.4% | -87.0% | -50.5% | -25.9% | – | – | – | – | – | – | – | – |
| Return on assets | -55.5% | -42.8% | -41.7% | -67.2% | -73.0% | -44.4% | -24.4% | – | – | – | – | – | – | – | – |
| Return on tangible assets | -55.5% | -42.8% | -41.7% | -67.2% | -73.0% | -44.4% | -24.4% | – | – | – | – | – | – | – | – |
| Return on invested capital | – | – | – | – | – | – | – | – | -169.2% | – | – | – | – | – | – |
| Return on capital employed | – | – | – | – | – | -52.7% | -28.3% | -20.7% | -89.4% | – | – | – | – | – | – |
| Return on total capital | – | – | – | – | – | – | – | – | -89.4% | – | – | – | – | – | – |
| NOPAT | – | – | – | – | – | -$23.87M | -$17.68M | -$8.46M | -$9.77M | – | – | – | – | – | – |
| Cash flow quality | |||||||||||||||
| OCF / Sales | – | – | – | – | – | – | – | -442.7% | -1,112.2% | -2,597.2% | – | – | – | – | – |
| OCF / Net income | 0.61 | 0.78 | 0.89 | 1.04 | 1.01 | 0.91 | 0.73 | – | – | – | – | – | – | – | – |
| FCF / OCF | – | – | – | 100.0% | 100.0% | 100.2% | 100.1% | 101.0% | 100.1% | 100.1% | 101.9% | 108.3% | 100.5% | 101.0% | – |
| FCF / Net income | – | – | – | 1.04 | 1.01 | 0.92 | 0.73 | – | – | – | – | – | – | – | – |
| FCF / EBITDA | – | – | – | – | – | 87.3% | 66.9% | 88.2% | 99.6% | – | – | – | – | – | – |
| Unlevered free cash flow | – | – | – | -$18.51M | -$32.90M | -$26.33M | -$14.95M | -$9.11M | -$12.08M | -$12.15M | -$8.63M | -$10.01M | -$2.54M | -$3.11M | – |
| Levered free cash flow | – | – | – | -$18.51M | -$32.90M | -$26.33M | -$14.95M | -$9.11M | -$12.08M | -$12.15M | -$8.63M | -$10.01M | -$2.54M | -$3.11M | – |
| Efficiency | |||||||||||||||
| Asset turnover | – | – | – | – | – | 0.00 | 0.00 | 0.04 | 0.06 | 0.02 | 0.00 | 0.00 | – | – | – |
| Fixed asset turnover | – | – | – | – | – | 0.00 | 0.00 | 5.95 | 1.79 | 0.58 | 0.00 | 0.00 | – | – | – |
| Receivables turnover | – | – | – | – | – | 0.00 | 0.00 | 10.93 | 4.94 | 1.41 | 0.00 | 0.00 | – | – | – |
| Days sales outstanding | – | – | – | – | – | – | – | 33.4 | 73.8 | 259.1 | – | – | – | – | – |
| CapEx to revenue | – | – | – | – | – | – | – | 4.4% | 1.1% | 3.6% | – | – | – | – | – |
| CapEx to OCF | – | – | – | -0.02% | -0.03% | -0.17% | -0.08% | -1.00% | -0.10% | -0.14% | -1.9% | -8.3% | -0.52% | -1.0% | – |
| CapEx to depreciation | – | – | – | 0.11 | 0.26 | 1.13 | 0.34 | 0.23 | 0.05 | 0.10 | 3.18 | 85.56 | 3.25 | 6.40 | – |
| Liquidity | |||||||||||||||
| Current ratio | 6.55 | 7.42 | 4.81 | 4.76 | 6.13 | 6.47 | 11.02 | 33.41 | 4.98 | 3.44 | 9.20 | 28.76 | 0.09 | – | – |
| Quick ratio | 6.55 | 7.42 | 4.81 | 4.76 | 6.13 | 6.47 | 11.02 | 33.41 | 4.98 | 3.44 | 9.20 | 28.76 | 0.09 | – | – |
| Cash ratio | 3.87 | 5.45 | 3.78 | 4.46 | 5.92 | 5.88 | 6.33 | 11.17 | 3.38 | 0.68 | 1.64 | 26.60 | 0.08 | – | – |
| Working capital | $15.78M | $13.95M | $10.49M | $11.63M | $30.18M | $43.80M | $69.50M | $87.70M | $15.30M | $11.15M | $20.84M | $31.03M | -$1.54M | – | – |
| Net current asset value | $15.78M | $13.95M | $10.49M | $11.59M | $29.95M | $43.58M | $69.14M | $87.70M | $15.30M | $10.36M | $20.66M | $30.63M | -$1.96M | – | – |
| Leverage | |||||||||||||||
| Total debt | – | – | – | – | – | – | – | – | $0 | $796.00K | $177.00K | $400.00K | $428.00K | – | – |
| Net debt | – | – | – | – | – | – | – | – | -$13.02M | -$2.30M | -$3.98M | -$29.34M | $291.00K | – | – |
| Debt / Equity | – | – | – | – | – | – | – | – | 0.00 | 0.07 | 0.01 | 0.01 | -0.22 | – | – |
| Debt ratio | – | – | – | – | – | – | – | – | 0.00% | 4.8% | 0.73% | 1.2% | 257.8% | – | – |
| Assets to equity | 1.18 | 1.13 | 1.20 | 1.23 | 1.20 | 1.19 | 1.10 | 1.03 | 1.24 | 1.49 | 1.13 | 1.05 | -0.09 | – | – |
| Long-term debt to assets | – | – | – | – | – | – | – | – | 0.00% | 4.8% | 0.73% | 1.2% | 257.8% | – | – |
| Long-term debt to equity | – | – | – | – | – | – | – | – | 0.00 | 0.07 | 0.01 | 0.01 | -0.22 | – | – |
| Total debt / Capitalization | – | – | – | – | – | – | – | – | 0.00% | 6.7% | 0.81% | 1.3% | -28.1% | – | – |
| Long-term debt / Capitalization | – | – | – | – | – | – | – | – | 0.00% | 6.7% | 0.81% | 1.3% | -28.1% | – | – |
| Net debt / EBITDA | – | – | – | – | – | – | – | – | 1.07 | – | – | – | – | – | – |
| Total debt / EBITDA | – | – | – | – | – | – | – | – | -0.00 | – | – | – | – | – | – |
| Cash flow to debt | – | – | – | – | – | – | – | – | – | -1,523.7% | -4,787.6% | -2,310.3% | -589.7% | – | – |
| Per share | |||||||||||||||
| Revenue per share | – | – | – | – | – | 0.00 | 0.00 | 139.63 | 108.24 | 55.35 | 0.00 | 0.00 | – | – | – |
| EPS (basic) | 19.12 | 64.64 | 240.00 | 1,022.40 | 1,900.80 | 1,944.00 | 1,396.80 | – | – | – | – | – | – | – | – |
| EPS (diluted) | 19.12 | 64.64 | 240.00 | 1,022.40 | 1,900.80 | – | – | – | – | – | – | – | – | – | – |
| Book value per share | 19.18 | 78.45 | 193.52 | 761.42 | 1,750.39 | 2,981.30 | 4,758.38 | 6,021.79 | 1,575.72 | 1,312.67 | 2,794.79 | 4,074.07 | -278,714.29 | -574.96 | – |
| Tangible book value per share | 19.18 | 78.45 | 193.52 | 761.42 | 1,750.39 | 2,981.30 | 4,758.38 | 6,021.79 | 1,575.72 | 1,312.67 | 2,794.79 | 4,074.07 | -278,714.29 | -574.96 | – |
| Cash per share | 13.38 | 56.87 | 144.86 | 781.95 | 1,998.22 | 3,178.87 | 2,988.35 | 2,070.84 | 1,298.98 | 367.07 | 539.11 | 3,857.31 | 19,571.43 | 208.60 | – |
| Operating cash flow per share | -7.68 | -28.25 | -85.57 | -1,049.46 | -1,887.85 | -1,774.95 | -1,017.51 | -618.18 | -1,203.81 | -1,437.60 | -1,099.23 | -1,198.73 | -360,571.43 | -894.54 | – |
| Free cash flow per share | – | – | – | -1,049.69 | -1,888.48 | -1,777.92 | -1,018.32 | -624.35 | -1,205.01 | -1,439.61 | -1,119.86 | -1,298.61 | -362,428.57 | -903.83 | – |
| CapEx per share | – | – | – | 0.23 | 0.63 | 2.97 | 0.82 | 6.17 | 1.20 | 2.01 | 20.63 | 99.88 | 1,857.14 | 9.30 | – |
| Valuation at period end | |||||||||||||||
| Market cap | $4.11M | $1.69M | $762.68K | $12.54M | $45.65M | $65.79M | $122.08M | $142.84M | $111.81M | $38.97M | $84.48M | $58.46K | – | – | – |
| Enterprise value | -$7.38M | -$6.09M | -$7.85M | -$9.84M | -$3.60M | $32.83M | $81.02M | $136.68M | $110.21M | $36.25M | $55.14M | $349.46K | – | – | – |
| P/S | – | – | – | – | – | – | – | 70.1x | 103x | 83.4x | – | – | – | – | – |
| P/B | 0.3x | 0.1x | 0.1x | 0.9x | 1.5x | 1.5x | 1.7x | 1.6x | 7.1x | 3.5x | 3.9x | 0.0x | – | – | – |
| P/TBV | 0.3x | 0.1x | 0.1x | 0.9x | 1.5x | 1.5x | 1.7x | 1.6x | 7.1x | 3.5x | 3.9x | 0.0x | – | – | – |
| P/OCF | -0.7x | -0.3x | -0.1x | -0.7x | -1.4x | -2.5x | -8.2x | -15.8x | -9.3x | -3.2x | -10.0x | -0.0x | – | – | – |
| EV/Sales | – | – | – | – | – | – | – | 67.1x | 102x | 77.6x | – | – | – | – | – |
| EV/OCF | 1.2x | 1.0x | 1.3x | 0.5x | 0.1x | -1.2x | -5.4x | -15.1x | -9.1x | -3.0x | -6.5x | -0.0x | – | – | – |
| EV/FCF | – | – | – | 0.5x | 0.1x | – | – | – | – | – | – | – | – | – | – |
| Earnings yield | -250.7% | -444.7% | -906.3% | -142.4% | -71.1% | -43.7% | -16.8% | – | – | – | – | – | – | – | – |
| FCF yield | – | – | – | -147.5% | -72.1% | -40.0% | -12.2% | -6.4% | -10.8% | -31.2% | -10.2% | -17,123.4% | – | – | – |
| Cost structure | |||||||||||||||
| R&D to revenue | – | – | – | – | – | – | – | 407.9% | 889.4% | 3,055.9% | – | – | – | – | – |
| Stock-based comp to revenue | – | – | – | – | – | – | – | 87.5% | 128.5% | 348.6% | – | – | – | – | – |
| Per employee | |||||||||||||||
| Total employees | 6 | 6 | 8 | 10 | 24 | 24 | 21 | 21 | 17 | 16 | 17 | 15 | 15 | 15 | 15 |
| Revenue per employee | – | – | – | – | – | $0 | $0 | $97.05K | $63.82K | $29.19K | $0 | $0 | – | – | – |
| Operating profit per employee | – | – | – | – | – | -$1.26M | -$1.07M | -$510.24K | -$727.29K | – | – | – | – | – | – |
| Net income per employee | -$1.72M | -$1.25M | -$864.00K | -$1.79M | -$1.35M | -$1.20M | -$974.33K | – | – | – | – | – | – | – | – |
| Free cash flow per employee | – | – | – | -$1.85M | -$1.37M | -$1.10M | -$711.86K | -$433.95K | -$710.53K | -$759.13K | -$507.82K | -$667.40K | -$169.13K | -$207.40K | – |
| Growth | |||||||||||||||
| Revenue 1Y growth | – | – | – | – | – | – | -100.0% | 87.8% | 132.3% | – | – | – | – | – | – |
| EBIT 1Y growth | – | – | – | – | – | -35.0% | -108.8% | 13.3% | – | – | – | – | – | – | – |
| EBITDA 1Y growth | – | – | – | – | – | -35.0% | -116.3% | 14.8% | – | – | – | – | – | – | – |
| Net income 1Y growth | -37.1% | -8.8% | 61.3% | 45.0% | -12.8% | -40.6% | – | – | – | – | – | – | – | – | – |
| Diluted EPS 1Y growth | -70.4% | -73.1% | -76.5% | -46.2% | – | – | – | – | – | – | – | – | – | – | – |
| Diluted EPS 3Y CAGR | -73.5% | -67.6% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Operating cash flow 1Y growth | -7.4% | 4.2% | 66.8% | 43.8% | -25.1% | -76.0% | -65.5% | 25.2% | 0.51% | -43.1% | 8.3% | -266.1% | 18.0% | – | – |
| Free cash flow 1Y growth | – | – | – | 43.8% | -25.0% | -76.1% | -64.0% | 24.6% | 0.55% | -40.7% | 13.8% | -294.6% | 18.5% | – | – |
| CapEx 1Y growth | – | – | – | -63.6% | -75.0% | 266.7% | -86.7% | 650.0% | -29.4% | -89.3% | -79.4% | 5,823.1% | -59.4% | – | – |
| CapEx 3Y CAGR | – | – | – | -30.7% | -50.4% | 54.2% | -11.0% | -17.3% | -75.0% | 9.4% | 70.6% | – | – | – | – |
| CapEx 5Y CAGR | – | – | – | -19.7% | -8.3% | -22.7% | -56.5% | 47.3% | -17.8% | – | – | – | – | – | – |
| CapEx 10Y CAGR | – | – | – | -18.8% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 0.69% | 11.3% | 0.41% | -54.8% | -30.1% | -32.1% | -14.9% | 361.2% | 19.4% | -32.2% | -26.3% | 19,734.3% | – | – | – |
| Total assets 3Y CAGR | 4.0% | -20.3% | -31.8% | -40.1% | -26.1% | 38.7% | 67.4% | 55.1% | -15.8% | 362.8% | – | – | – | – | – |
| Total assets 5Y CAGR | -18.7% | -24.8% | -28.8% | -3.4% | 17.3% | 16.6% | 18.6% | 252.7% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | -2.6% | -5.6% | 58.5% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -3.3% | 17.6% | 3.4% | -56.0% | -30.9% | -36.8% | -20.5% | 456.5% | 42.6% | -48.6% | -31.4% | 1,709.8% | 1.4% | 27.0% | – |
| Total equity 3Y CAGR | 5.5% | -18.8% | -32.0% | -42.3% | -29.7% | 40.9% | 84.8% | 59.8% | -20.5% | – | – | – | – | – | – |
| Total equity 5Y CAGR | -18.6% | -25.2% | -30.9% | -3.2% | 22.5% | 15.4% | 17.3% | – | – | – | – | – | – | – | – |
| Total equity 10Y CAGR | -3.1% | -6.3% | – | – | – | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.